Login/Sign Up
₹657.9*
MRP ₹731
10% off
₹621.35*
MRP ₹731
15% CB
₹109.65 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Invista 50 Tablet 10's to prevent serious adverse effects.
Pregnancy
Unsafe
When given to a pregnant woman, Invista 50 Tablet 10's may cause fetal harm. There have been no sufficient and well-controlled investigations of Invista 50 Tablet 10's in pregnant women. Women of reproductive potential should avoid becoming pregnant while undergoing treatment with this medicine.
Breast Feeding
Unsafe
It is not known if Invista 50 Tablet 10's passes into your breast milk. Inform your doctor if you are breastfeeding. You should not breastfeed while taking this medicine and for 2 weeks of the treatment with Invista 50 Tablet 10's. Your doctor may prescribe an alternative based on the symptoms and health condition.
Driving
Unsafe
Invista 50 Tablet 10's may cause dizziness and may make you feel drowsy. Hence, avoid driving or operating machines after taking Invista 50 Tablet 10's or until you become alert.
Liver
Caution
Use Invista 50 Tablet 10's with caution if you have liver disease. Your doctor may monitor your liver function while taking this medicine. No dose adjustments are necessary in patients with liver impairment.
Kidney
Caution
There are presently no clinical investigations with Invista 50 Tablet 10's in patients with compromised renal function. If you have kidney problems, inform your doctor before taking this medicine.
Children
Consult your doctor
Invista 50 Tablet 10's is safe for use in children above one year of age if prescribed by the doctor.
Product Substitutes
About Invista 50 Tablet 10's
Invista 50 Tablet 10's is an anti-cancer medicine used in the treatment of Leukemia. Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. There are different types of blood cancers. Invista 50 Tablet 10's is used in the treatment of chronic myelogenous leukemia (CML) in patients with chronic, accelerated, or blast phase Ph+ (Philadelphia chromosome-positive) who are resistant or intolerant to prior therapy, in patients with newly diagnosed chronic Ph+ chronic myelogenous leukemia (CML). This medicine is also used in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
Invista 50 Tablet 10's contains Dasatinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body.
Invista 50 Tablet 10's may cause certain side effects, such as skin rash, fatigue, headache, musculoskeletal pain, decreased platelet count, nausea, vomiting, diarrhea, abdominal pain, dizziness, GI bleeding, muscle inflammation, myalgia, and difficulty breathing. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Invista 50 Tablet 10's should be taken as advised by your doctor. Do not take more than the recommended dose of medicine. Your doctor will decide the dose of Invista 50 Tablet 10's based on the severity of your condition.
Invista 50 Tablet 10's should be avoided if you are allergic to it or any other components present in it. Before taking Invista 50 Tablet 10's, caution should be exercised if you have/had liver/kidney disease, gastrointestinal disorders, cardiac problems, and myelosuppression as may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment with Invista 50 Tablet 10's. Breastfeeding should be discontinued in nursing mothers during the treatment.
Uses of Invista 50 Tablet 10's
Medicinal Benefits
Invista 50 Tablet 10's contains Dasatinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins (BCR-ABL tyrosine kinase) that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. Invista 50 Tablet 10's is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.
Directions for Use
Side Effects of Invista 50 Tablet 10's
Drug Warnings
Invista 50 Tablet 10's should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before taking, inform your doctor if you have liver/kidney disease, diabetes, cardiac problems, increased blood pressure, or gastrointestinal disorders, as the use of Invista 50 Tablet 10's in these patients may cause serious side effects. Invista 50 Tablet 10's may cause myelosuppression, fluid retention, gastrointestinal haemorrhage, QT prolongation, congestive heart failure, Left ventricular dysfunction and Myocardial infarction. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Breastfeeding should be discontinued in nursing mothers during the treatment. Invista 50 Tablet 10's is given in children above one year of age only if prescribed by the doctor. Avoid alcohol consumption and smoking, as it can lead to serious adverse effects.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise